{"cursor":"8091","size":15,"audio":[],"currentlang":"en","article":"\n\n\n\nThe 'half maximal inhibitory concentration (IC 50 )' is a measure of\nthe effectiveness of a compound in inhibiting biological or biochemical\nfunction. This quantitative measure indicates how much of a particular drug or\nother substance (inhibitor) is needed to inhibit a given biological process (or\ncomponent of a process, i.e. an enzyme, cell, cell receptor or microorganism) by\nhalf. In other words, it is the half maximal (50%) inhibitory concentration (IC)\nof a substance (50% IC, or IC 50 ). It is commonly used as a measure of\nantagonist drug potency in pharmacological research. According to the FDA,\nIC 50 represents the concentration of a drug that is required for 50%\ninhibition in vitro. [http://www.fda.gov/ohrms/dockets/ac/00/slides/3621s1d/sld036.htm IC50\nversus EC50 ] It is comparable to an\nEC 50 for agonist drugs. EC 50 also represents the plasma\nconcentration required for obtaining 50% of a maximum effect in vivo.\n","linknr":169,"url":"IC50","recorded":1374768842,"links":["/w/index.php?title=IC50&action=edit","/w/index.php?title=IC50&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Mergefrom.svg/50px-Mergefrom.svg.png","/wiki/Pic50","/wiki/Wikipedia:Merging","/wiki/Talk:IC50","/wiki/File:Example_IC50_curve_demonstrating_visually_how_IC50_is_derived.png","//upload.wikimedia.org/wikipedia/commons/thumb/8/81/Example_IC50_curve_demonstrating_visually_how_IC50_is_derived.png/220px-Example_IC50_curve_demonstrating_visually_how_IC50_is_derived.png","/wiki/File:Example_IC50_curve_demonstrating_visually_how_IC50_is_derived.png","//bits.wikimedia.org/static-1.22wmf8/skins/common/images/magnify-clip.png","/wiki/Enzyme_inhibitor","/wiki/Enzyme","/wiki/Cell_(biology)","/wiki/Cell_receptor","/wiki/Microorganism","/wiki/Receptor_antagonists","/wiki/Potency_(pharmacology)","/wiki/Food_and_Drug_Administration","#cite_note-fda-1","/wiki/Half_maximal_effective_concentration","/wiki/Agonist","#cite_note-fda-1","#Determination_IC50_of_a_drug","#Functional_antagonist_assay","#Competition_binding_assays","#IC50_and_affinity","#pIC50","#Behavioral_Assays","#See_also","#References","#External_links","/w/index.php?title=IC50&action=edit&section=1","/w/index.php?title=IC50&action=edit&section=2","/wiki/Dose-response_relationship","#cite_note-web-2","/wiki/Adenosine_triphosphate","/wiki/Competitive_inhibition","/w/index.php?title=IC50&action=edit&section=3","/wiki/Dissociation_constant","#cite_note-web-2","#cite_note-Glaxo-3","/w/index.php?title=IC50&action=edit&section=4","#cite_note-cheng-4","//upload.wikimedia.org/math/1/5/0/1504611269ebb94adfb0ebffed40bf85.png","#cite_note-Lazareno-5","//upload.wikimedia.org/math/9/6/d/96db39411c1ca77649e79f7bc37b4851.png","#cite_note-Glaxo-3","#cite_note-Lazareno-5","/w/index.php?title=IC50&action=edit&section=5","//upload.wikimedia.org/math/5/1/0/5109fc00ad171425ff8f48ab7523b312.png","/wiki/Molar_concentration","#cite_note-stewart-6","/w/index.php?title=IC50&action=edit&section=6","#cite_note-7","/w/index.php?title=IC50&action=edit&section=7","/wiki/Certain_safety_factor","/wiki/Dose-response_relationship","/wiki/EC50","/wiki/LD50","/w/index.php?title=IC50&action=edit&section=8","#cite_ref-fda_1-0","#cite_ref-fda_1-1","http://www.fda.gov/ohrms/dockets/ac/00/slides/3621s1d/sld036.htm","#cite_ref-web_2-0","#cite_ref-web_2-1","http://www.ncgc.nih.gov/guidance/section3.html","#cite_ref-Glaxo_3-0","#cite_ref-Glaxo_3-1","http://www.pdg.cnb.uam.es/cursos/Barcelona2002/pages/Farmac/Comput_Lab/Guia_Glaxo/chap3c.html","#cite_ref-cheng_4-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2F0006-2952%2873%2990196-2","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/4202581","#cite_ref-Lazareno_5-0","#cite_ref-Lazareno_5-1","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175764","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2175764","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/8401922","//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/8401922&action=edit&editintro=Template:Cite_pmid/editintro2","#cite_ref-stewart_6-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1111%2Fj.1365-2125.1983.tb02136.x","#cite_ref-7","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/8739548","/w/index.php?title=IC50&action=edit&section=9","http://www.ReaderFit.com","http://www.sanjeevslab.org/tools.html","http://www.antimalarial-icestimator.net/","http://botdb.abcc.ncifcrf.gov/toxin/kiConverter.jsp","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=IC50&oldid=558836758","/wiki/Help:Categories","/wiki/Category:Pharmacodynamics","/wiki/Category:Articles_to_be_merged_from_January_2013","/wiki/Category:All_articles_to_be_merged","/w/index.php?title=Special:UserLogin&returnto=IC50&type=signup","/w/index.php?title=Special:UserLogin&returnto=IC50","/wiki/IC50","/wiki/Talk:IC50","#","/wiki/IC50","/w/index.php?title=IC50&action=edit","/w/index.php?title=IC50&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf10/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","//donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/IC50","/wiki/Special:RecentChangesLinked/IC50","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=IC50&oldid=558836758","/w/index.php?title=IC50&action=info","//www.wikidata.org/wiki/Q286779","/w/index.php?title=Special:Cite&page=IC50&id=558836758","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=IC50","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=IC50&oldid=558836758&writer=rl","/w/index.php?title=IC50&printable=yes","//de.wikipedia.org/wiki/IC50","//fr.wikipedia.org/wiki/Concentration_inhibitrice_m%C3%A9diane","//it.wikipedia.org/wiki/IC50","//ja.wikipedia.org/wiki/IC50","//ru.wikipedia.org/wiki/IC50","//simple.wikipedia.org/wiki/IC50","//fi.wikipedia.org/wiki/IC50","//uk.wikipedia.org/wiki/IC50","#","//www.wikidata.org/wiki/Q286779#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/IC50","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf10/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["biology","pharmacology"],"pdf":[],"categories":["Pharmacodynamics"],"headings":["Determination IC<sub>50</sub> of a drug","See also","References","External links"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Mergefrom.svg/50px-Mergefrom.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/8/81/Example_IC50_curve_demonstrating_visually_how_IC50_is_derived.png/220px-Example_IC50_curve_demonstrating_visually_how_IC50_is_derived.png","//bits.wikimedia.org/static-1.22wmf8/skins/common/images/magnify-clip.png","//upload.wikimedia.org/math/1/5/0/1504611269ebb94adfb0ebffed40bf85.png","//upload.wikimedia.org/math/9/6/d/96db39411c1ca77649e79f7bc37b4851.png","//upload.wikimedia.org/math/5/1/0/5109fc00ad171425ff8f48ab7523b312.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf10/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf10/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["cell","biology"],["potency","pharmacology"]],"members":["cell","potency"],"related":["Enzyme_inhibitor","Enzyme","Cell_(biology)","Cell_receptor","Microorganism","Receptor_antagonists","Potency_(pharmacology)","Food_and_Drug_Administration","Half_maximal_effective_concentration","Agonist","Dose-response_relationship","Adenosine_triphosphate","Competitive_inhibition","Dissociation_constant","Molar_concentration","Certain_safety_factor","Dose-response_relationship","EC50","LD50"]}